SEARCH

SEARCH BY CITATION

References

  • Abbracchio M. P., Burnstock G., Boeynaems J. M. et al. (2006) International union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol. Rev. 58, 281341.
  • Amisten S., Melander O., Wihlborg A. K., Berglund G. and Erlinge D. (2007) Increased risk of acute myocardial infarction and elevated levels of C-reactive protein in carriers of the Thr-87 variant of the ATP receptor P2Y11. Eur. Heart J. 28, 1318.
  • Berchtold S., Ogilvie A. L., Bogdan C., Muhl-Zurbes P., Ogilvie A., Schuler G. and Steinkasserer A. (1999) Human monocyte derived dendritic cells express functional P2X and P2Y receptors as well as ecto-nucleotidases. FEBS Lett. 458, 424428.
  • Black S., Kushner I. and Samols D. (2004) C-reactive protein. J. Biol. Chem. 279, 4848748490.
  • Communi D., Motte S., Boeynaems J. M. and Pirotton S. (1996) Pharmacological characterization of the human P2Y4 receptor. Eur. J. Pharmacol. 317, 383389.
  • Communi D., Govaerts C., Parmentier M. and Boeynaems J. M. (1997) Cloning of a human purinergic P2Y receptor coupled to phospholipase C and adenylyl cyclase. J. Biol. Chem. 272, 3196931973.
  • Communi D., Robaye B. and Boeynaems J.-M. (1999) Pharmacological characterization of the human P2Y11 receptor. Br. J. Pharmacol. 128, 11991206.
  • Di Virgilio F., Boeynaems J. M. and Robson S. C. (2009) Extracellular nucleotides as negative modulators of immunity. Curr. Opin. Pharmacol. 9, 507513.
  • Ecke D., Tulapurkar M. E., Nahum V., Fischer B. and Reiser G. (2006) Opposite diastereoselective activation of P2Y1 and P2Y11 nucleotide receptors by adenosine 5′-O-(α-boranotriphosphate) analogues. Br. J. Pharmacol. 149, 416423.
  • Ecke D., Hanck T., Tulapurkar M. E., Schafer R., Kassack M., Stricker R. and Reiser G. (2008) Hetero-oligomerization of the P2Y11 receptor with the P2Y1 receptor controls the internalization and ligand selectivity of the P2Y11 receptor. Biochem. J. 409, 107116.
  • Ginsburg-Shmuel T., Haas M., Schumann M., Reiser G., Kalid O., Stern N. and Fischer B. (2010) 5-OMe-UDP is a potent and selective P2Y6-receptor agonist. J. Med. Chem. 53, 16731685.
  • Gorini S., Callegari G., Romagnoli G. et al. (2010) ATP secreted by endothelial cells blocks CX3CL 1-elicited natural killer cell chemotaxis and cytotoxicity via P2Y11 receptor activation. Blood 116, 44924500.
  • Haas M., Ben-Moshe I., Fischer B. and Reiser G. (2013) Sp-2-propylthio-ATP-α-B and Sp-2-propylthio-ATP-α-B, β-γ-dichloromethylene are novel potent and specific agonists of the human P2Y11 receptor. Biochem. Pharmacol. 86, 645655.
  • Hoffmann C., Ziegler N., Reiner S., Krasel C. and Lohse M. J. (2008) Agonist-selective, receptor-specific interaction of human P2Y receptors with beta-arrestin-1 and -2. J. Biol. Chem. 283, 3093330941.
  • Kohout T. A. and Lefkowitz R. J. (2003) Regulation of G protein-coupled receptor kinases and arrestins during receptor desensitization. Mol. Pharmacol. 63, 918.
  • Kornum B. R., Kawashima M., Faraco J. et al. (2011) Common variants in P2RY11 are associated with narcolepsy. Nat. Genet. 43, 6671.
  • Meis S., Hamacher A., Hongwiset D. et al. (2010) NF546 [4,4′-(carbonylbis(imino-3,1-phenylene-carbonylimino-3,1-(4-methyl-phenylene)-car bonylimino))-bis(1,3-xylene-alpha, alpha'-diphosphonic acid) tetrasodium salt] is a non-nucleotide P2Y11 agonist and stimulates release of interleukin-8 from human monocyte-derived dendritic cells. J. Pharmacol. Exp. Ther. 332, 238247.
  • Moore D. J., Chambers J. K., Wahlin J. P., Tan K. B., Moore G. B., Jenkins O., Emson P. C. and Murdock P. R. (2001) Expression pattern of human P2Y receptor subtypes: a quantitative reverse transcription-polymerase chain reaction study. Biochim. Biophys. Acta 1521, 107119.
  • Mundell S. J., Luo J., Benovic J. L., Conley P. B. and Poole A. W. (2006) Distinct clathrin-coated pits sort different G protein-coupled receptor cargo. Traffic 7, 14201431.
  • Murthy K. S. and Makhlouf G. M. (1998) Coexpression of ligand-gated P2X and G protein-coupled P2Y receptors in smooth muscle. Preferential activation of P2Y receptors coupled to phospholipase C (PLC)-β1 via Gαq/11 and to PLC-β3 via Gβγi3. J. Biol. Chem. 273, 46954704.
  • Sakaki H., Tsukimoto M., Harada H., Moriyama Y. and Kojima S. (2013) Autocrine regulation of macrophage activation via exocytosis of ATP and activation of P2Y11 receptor. PLoS ONE 8, e59778.
  • Schnurr M., Toy T., Stoitzner P., Cameron P., Shin A., Beecroft T., Davis I. D., Cebon J. and Maraskovsky E. (2003) ATP gradients inhibit the migratory capacity of specific human dendritic cell types: implications for P2Y11 receptor signaling. Blood 102, 613620.
  • Tabas I. (2010) Macrophage death and defective inflammation resolution in atherosclerosis. Nat. Rev. Immunol. 10, 3646.
  • Tulapurkar M. E., Laubinger W., Nahum V., Fischer B. and Reiser G. (2004) Subtype specific internalization of P2Y1 and P2Y2 receptors induced by novel adenosine 5′-O-(1-boranotriphosphate) derivatives. Br. J. Pharmacol. 142, 869878.
  • Tulapurkar M. E., Zündorf G. and Reiser G. (2006) Internalization and desensitization of a green fluorescent protein-tagged P2Y nucleotide receptor are differently controlled by inhibition of calmodulin-dependent protein kinase II. J. Neurochem. 96, 624634.
  • Vaughan K. R., Stokes L., Prince L. R. et al. (2007) Inhibition of neutrophil apoptosis by ATP is mediated by the P2Y11 receptor. J. Immunol. 179, 85448553.
  • Vitiello L., Gorini S., Rosano G. and la Sala A. (2012) Immunoregulation through extracellular nucleotides. Blood 120, 511518.
  • Wang L., Östberg O., Wihlborg A. K., Brogren H., Jern S. and Erlinge D. (2003) Quantification of ADP and ATP receptor expression in human platelets. J. Thromb. Haemost. 1, 330336.
  • Wang L., Jacobsen S. E., Bengtsson A. and Erlinge D. (2004) P2 receptor mRNA expression profiles in human lymphocytes, monocytes and CD34 +  stem and progenitor cells. BMC Immunol. 5, 16.
  • Wihlborg A. K., Balogh J., Wang L. et al. (2006) Positive inotropic effects by uridine triphosphate (UTP) and uridine diphosphate (UDP) via P2Y2 and P2Y6 receptors on cardiomyocytes and release of UTP in man during myocardial infarction. Circ. Res. 98, 970976.
  • Wilkin F., Duhant X., Bruyns C., Suarez-Huerta N., Boeynaems J. M. and Robaye B. (2001) The P2Y11 receptor mediates the ATP-induced maturation of human monocyte-derived dendritic cells. J. Immunol. 166, 71727177.
  • Wilkin F., Stordeur P., Goldman M., Boeynaems J. M. and Robaye B. (2002) Extracellular adenine nucleotides modulate cytokine production by human monocyte-derived dendritic cells: dual effect on IL-12 and stimulation of IL-10. Eur. J. Immunol. 32, 24092417.
  • Zylberg J., Ecke D., Fischer B. and Reiser G. (2007) Structure and ligand-binding site characteristics of the human P2Y11 nucleotide receptor deduced from computational modelling and mutational analysis. Biochem. J. 405, 277286.